Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
31
self-reported 11–50 band
Founded
Not recorded
Legal entities
1
ACRA
Office countries
2
3 addresses
Funding rounds
5
Series A · Dec 2023 · US$ 27.0M
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
ENGINE BIOSCIENCES PTE. LTD.Entity record →
UEN201438228E
Legal entities
Show as table · Engine Biosciences: 1 registry entity
| ENGINE BIOSCIENCES PTE. LTD. | UEN 201438228E |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
Locations
2
Countries with an office address3 addresses on record
SingaporeprimaryUnited States
Country footprint
Show as table · Offices in 2 countries
| Countries | 2 |
|---|---|
| Primary country | SG |
All codes: SG US
Addresses
- SG21 Biopolis Road, Nucleos North Tower; #02-03/05; Singapore, Singapore 138567Primary
- SG160 Robinson Road; #23-02; Singapore, Singapore 068914
- US1400 Bridge Parkway; Suite 101; Redwood City, California 94065
Grid intelligence Members
Funding
Rounds5
Round typeSeries A · venture round
Amount (USD)27,000,000
Stage rank3
Investors named1
Since last round2 yr 1 mo
Funding
Show as table · 5 funding rounds
| Rounds | 5 |
|---|---|
| Axis | 2024 to 2026 |
| Series A · 1 Dec 2023 | US$ 27.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Engine Biosciences?
One Singapore entity on ACRA: ENGINE BIOSCIENCES PTE. LTD. (UEN 201438228E), high confidence.
How many people work at Engine Biosciences?
31 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Engine Biosciences have offices?
Three addresses on record across 2 countries. Primary: 21 Biopolis Road, Nucleos North Tower, #02-03/05, Singapore 138567.
Has Engine Biosciences raised funding?
Five rounds. Latest 1 December 2023: Series A, US$27,000,000, investor Polaris Partners.
Which companies are listed alongside Engine Biosciences?
22 profiles list Engine Biosciences as a peer — 94th percentile in Biotechnology Research. It lists ten peers of its own. Hummingbird Bioscience and Albatroz Therapeutics list it back.